Stanley Plotkin
Stanley Alan Plotkin is an American physician who specializes in vaccines.
History
In July 2015, the New England Journal of Medicine published a paper co-authored by Plotkin, Jeremy Farrar and Adel Mahmoud, calling for the formation of a global funding mechanism for vaccine development.1) This idea later became the Coalition for Epidemic Preparedness Innovations (CEPI) which launched at the World Economic Forum in 2017 with funding from Wellcome Trust, the Bill & Melinda Gates Foundation and a number of national governments.2)
Affiliations
Pharmaceutical companies
In a 2015 disclosure of interest, Plotkin revealed he received personal fees from Dynavax, Emergent BioSolutions, Geovax, HOOKIPA Pharma, Inovio Pharmaceuticals, Merck, Pfizer, and Sanofi Pasteur.3)
1)
Plotkin, S. A., Mahmoud, A. A. F., & Farrar, J. (2015). Establishing a Global Vaccine-Development Fund. New England Journal of Medicine, 373(4), 297–300. https://doi.org/10.1056/nejmp1506820
2)
Solberg, E. (2017, January 20). $460 Million Coalition for Epidemic Preparedness Innovation Launched. Philanthropy News Digest. https://web.archive.org/web/20220112055033/https://philanthropynewsdigest.org/news/460-million-coalition-for-epidemic-preparedness-innovation-launched
3)
Plotkin, S. (2015). ICMJE Form for Disclosure of Potential Conflicts of Interest (p. 8). New England Journal of Medicine. https://web.archive.org/web/20221020003030/https://www.nejm.org/doi/suppl/10.1056/NEJMp1506820/suppl_file/nejmp1506820_disclosures.pdf